SEC Form 4 · accession 0001225208-18-003868
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B. Ullem
Officer — CVP, CFO
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 6:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2018 | F | 11,643 | $133.82 | D | 25,023 | D | |
| Common Stock | Feb 20, 2018 | G | 14,055 | $0.00 | D | 10,968 | D | |
| Common Stock | Feb 20, 2018 | G | 14,055 | $0.00 | A | 61,659 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. An updated Power of Attorney is attached.